Sphera Funds Management as of June 30, 2016
Portfolio Holdings for Sphera Funds Management
Sphera Funds Management holds 91 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | 7.8 | $30M | 600k | 50.23 | |
| Allergan | 5.7 | $22M | 95k | 231.09 | |
| Shire | 5.6 | $22M | 265k | 81.65 | |
| Gilead Sciences (GILD) | 4.2 | $16M | 193k | 83.42 | |
| Eli Lilly & Co. (LLY) | 4.1 | $16M | 200k | 78.75 | |
| Celgene Corporation | 4.0 | $15M | 155k | 98.63 | |
| Pfizer (PFE) | 3.9 | $15M | 427k | 35.21 | |
| Amgen | 3.4 | $13M | 85k | 152.15 | |
| Biogen Idec (BIIB) | 3.2 | $12M | 51k | 241.82 | |
| Mylan Nv | 2.8 | $11M | 250k | 43.24 | |
| Ituran Location And Control (ITRN) | 2.7 | $10M | 461k | 22.69 | |
| GlaxoSmithKline | 1.7 | $6.4M | 398k | 16.05 | |
| Biogen Idec Inc option | 1.6 | $6.0M | 250.00 | 24184.00 | |
| Merck & Co (MRK) | 1.5 | $5.8M | 100k | 57.61 | |
| Amicus Therapeutics (FOLD) | 1.4 | $5.5M | 1.0M | 5.46 | |
| Glycomimetics (GLYC) | 1.4 | $5.2M | 718k | 7.27 | |
| Ultragenyx Pharmaceutical (RARE) | 1.3 | $5.1M | 105k | 48.91 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.3 | $5.0M | 58k | 86.02 | |
| D Alexion Pharmaceutic Als Inc C Common Stock 0 | 1.3 | $4.9M | 42k | 116.77 | |
| Acadia Healthcare Company In | 1.3 | $4.9M | 1.5k | 3246.00 | |
| Achaogen | 1.2 | $4.8M | 1.3M | 3.79 | |
| Corvus Pharmaceuticals (CRVS) | 1.2 | $4.6M | 325k | 14.08 | |
| Advance Auto Parts (AAP) | 1.2 | $4.5M | 28k | 161.63 | |
| Neuroderm Ltd F | 1.1 | $4.2M | 259k | 16.25 | |
| Gilead Sciences Inc option | 1.1 | $4.2M | 500.00 | 8342.00 | |
| Adamas Pharmaceuticals | 1.1 | $4.1M | 270k | 15.14 | |
| Colucid Pharmaceuticals | 1.1 | $4.1M | 500k | 8.17 | |
| Tesaro | 1.0 | $3.8M | 450.00 | 8404.44 | |
| Keryx Biopharmaceuticals | 1.0 | $3.7M | 563k | 6.62 | |
| Gw Pharmaceuticals Plc ads | 0.9 | $3.7M | 40k | 91.58 | |
| Charter Communications Inc New Cl A cl a (CHTR) | 0.9 | $3.7M | 16k | 228.63 | |
| B Communications (BCOMF) | 0.9 | $3.6M | 149k | 23.89 | |
| Macrogenics (MGNX) | 0.9 | $3.5M | 130k | 26.99 | |
| Ascendis Pharma A S (ASND) | 0.9 | $3.5M | 262k | 13.27 | |
| ALNYLAM PHARMACEUTICALS INC. Common Stock cmn | 0.9 | $3.3M | 600.00 | 5548.33 | |
| Radius Health | 0.9 | $3.3M | 90k | 36.76 | |
| Sage Therapeutics Inc call | 0.8 | $3.0M | 1.0k | 3013.00 | |
| Eiger Biopharmaceuticals | 0.8 | $3.0M | 151k | 19.82 | |
| Genocea Biosciences | 0.8 | $2.9M | 709k | 4.10 | |
| Alphabet Inc Class A cs (GOOGL) | 0.8 | $2.9M | 4.2k | 703.51 | |
| Gw Pharmaceuticals Plc ads | 0.7 | $2.8M | 310.00 | 9158.06 | |
| Visa (V) | 0.7 | $2.8M | 38k | 74.17 | |
| Alder Biopharmaceuticals | 0.7 | $2.8M | 113k | 24.97 | |
| Clovis Oncology | 0.7 | $2.7M | 200k | 13.72 | |
| Retrophin | 0.7 | $2.7M | 150k | 17.81 | |
| Acorda Therapeutics | 0.7 | $2.5M | 98k | 25.50 | |
| Medgenics | 0.7 | $2.5M | 450k | 5.55 | |
| Kite Pharma | 0.7 | $2.5M | 50k | 50.00 | |
| Five Prime Therapeutics | 0.6 | $2.5M | 60k | 41.35 | |
| Relypsa | 0.6 | $2.4M | 130k | 18.50 | |
| Endo International (ENDPQ) | 0.6 | $2.3M | 150k | 15.59 | |
| Cynapsus Therapeutics | 0.6 | $2.2M | 134k | 16.75 | |
| Forward Pharma A/s | 0.6 | $2.2M | 122k | 18.17 | |
| Orbotech Ltd Com Stk | 0.6 | $2.2M | 84k | 25.56 | |
| Foamix Pharmaceuticals | 0.6 | $2.2M | 342k | 6.35 | |
| Clearside Biomedical (CLSD) | 0.6 | $2.1M | 300k | 7.01 | |
| Aldeyra Therapeutics (ALDX) | 0.5 | $2.1M | 369k | 5.69 | |
| Sage Therapeutics (SAGE) | 0.5 | $2.1M | 70k | 30.13 | |
| Dermira | 0.5 | $2.0M | 70k | 29.26 | |
| Paratek Pharmaceuticals | 0.5 | $1.9M | 140k | 13.91 | |
| Dbv Technologies S A (DBVT) | 0.5 | $2.0M | 61k | 32.62 | |
| Aduro Biotech | 0.5 | $1.9M | 170k | 11.31 | |
| Inotek Pharmaceuticals | 0.5 | $1.9M | 250k | 7.44 | |
| Bluebird Bio (BLUE) | 0.5 | $1.7M | 40k | 43.30 | |
| Summit Therapeutics Plc spons ads | 0.4 | $1.6M | 198k | 7.91 | |
| Marinus Pharmaceuticals | 0.4 | $1.5M | 1.2M | 1.27 | |
| Edge Therapeutics | 0.4 | $1.5M | 150k | 10.11 | |
| Egalet | 0.4 | $1.5M | 293k | 4.96 | |
| Fibrogen (FGEN) | 0.4 | $1.4M | 86k | 16.41 | |
| Valeant Pharmaceuticals Int | 0.4 | $1.4M | 69k | 20.15 | |
| Pieris Pharmaceuticals (PIRS) | 0.3 | $1.3M | 810k | 1.61 | |
| Ptc Therapeutics I (PTCT) | 0.3 | $1.2M | 175k | 7.02 | |
| Immune Design | 0.3 | $1.2M | 153k | 8.16 | |
| Trillium Therapeutics, Inc. Cmn | 0.3 | $1.2M | 132k | 8.98 | |
| Vistagen Therapeutics | 0.3 | $1.1M | 294k | 3.90 | |
| Servicemaster Global | 0.3 | $1.1M | 28k | 39.78 | |
| Arbutus Biopharma (ABUS) | 0.3 | $1.0M | 300k | 3.48 | |
| Cerulean Pharma | 0.2 | $954k | 450k | 2.12 | |
| Immunomedics | 0.2 | $928k | 400k | 2.32 | |
| Oncobiologics | 0.2 | $881k | 259k | 3.40 | |
| Mirati Therapeutics | 0.2 | $819k | 150k | 5.46 | |
| Horizon Pharma | 0.2 | $823k | 50k | 16.46 | |
| Catabasis Pharmaceuticals | 0.2 | $752k | 203k | 3.70 | |
| Sapiens Intl Corp N V | 0.2 | $714k | 61k | 11.71 | |
| Palatin Technologies | 0.1 | $447k | 1.0M | 0.44 | |
| Cytokinetics (CYTK) | 0.1 | $304k | 32k | 9.48 | |
| Abeona Therapeutics | 0.1 | $326k | 138k | 2.36 | |
| Scynexis | 0.1 | $279k | 129k | 2.17 | |
| Insys Therapeutics | 0.1 | $212k | 16k | 12.92 | |
| Ishares Tr Index option | 0.1 | $200k | 2.0k | 100.00 | |
| Ellomay Capital (ELLO) | 0.0 | $43k | 5.7k | 7.61 |
